Unique ID issued by UMIN | UMIN000043622 |
---|---|
Receipt number | R000049811 |
Scientific Title | Retrospective cohort study utilizing COVIREGI-JP to evaluate the efficacy of tocilizumab for severe COVID-19 pneumonia |
Date of disclosure of the study information | 2021/03/16 |
Last modified on | 2023/09/21 18:09:13 |
Retrospective cohort study utilizing COVIREGI-JP to evaluate the efficacy of tocilizumab for severe COVID-19 pneumonia
SL43051
Retrospective cohort study utilizing COVIREGI-JP to evaluate the efficacy of tocilizumab for severe COVID-19 pneumonia
SL43051
Japan |
COVID-19
Infectious disease |
Others
NO
To evaluate the efficacy of tocilizumab, administered to patients with severe COVID-19 pneumonia and were enrolled in JA42434 study against SOC population, by generating a synthetic control group from the SOC population in the COVIREGI-JP cohort.
Efficacy
Confirmatory
Pragmatic
Not applicable
Time until discharge or waiting for discharge (with normal body temperature and respiratory rate, stable oxygen saturation under ambient air or oxygenation of 2 L or less)
7-point scale clinical categorization
Observational
18 | years-old | <= |
Not applicable |
Male and Female
[Tocilizumab population in JA42434 study]
1)Patients administered with Tocilizumab in JA42434 study
[COVIREGI-JP Cohort]
1)Aged 18 years or older at the onset of COVID-19
2)Hospitalized between May 11, 2020 to Nov 18, 2020
[COVIREGI-JP cohort]
1)Pregnant women
2)Patients administered with any of the below during hospitalization
- Sarilumab
- Baricitinib
248
1st name | Norio |
Middle name | |
Last name | Ohmagari |
National Center for Global Health and Medicine
Disease Control and Prevention Center
162-8655
1-21-1, Toyama, Shinjuku, Tokyo
03-3202-7181
registry.covid@hosp.ncgm.go.jp
1st name | Noriaki |
Middle name | |
Last name | Matsunaga |
National Center for Global Health and Medicine
Disease Control and Prevention Center
162-8655
1-21-1, Toyama, Shinjuku, Tokyo
03-3202-7181
registry.covid@hosp.ncgm.go.jp
National Center for Global Health and Medicine
Chugai Pharmaceutical Co., Ltd.
Profit organization
National Center for Global Health and Medicine
1-21-1, Toyama, Shinjuku, Tokyo
03-3202-7181
kenkyu-shinsa@hosp.ncgm.go.jp
NO
2021 | Year | 03 | Month | 16 | Day |
Unpublished
No longer recruiting
2020 | Year | 12 | Month | 14 | Day |
2021 | Year | 02 | Month | 05 | Day |
2021 | Year | 03 | Month | 16 | Day |
2023 | Year | 06 | Month | 30 | Day |
None
2021 | Year | 03 | Month | 16 | Day |
2023 | Year | 09 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049811
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |